Antimicrobial peptides with cell-penetrating peptide properties and vice versa

被引:220
作者
Splith, Katrin [1 ]
Neundorf, Ines [1 ]
机构
[1] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany
来源
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS | 2011年 / 40卷 / 04期
关键词
Antimicrobial peptides; Drug delivery; Cell-penetrating peptides; Cellular uptake mechanism; LIPOPOLYSACCHARIDE-BINDING PROTEIN; VECTOR-MEDIATED STRATEGY; MAMMALIAN-CELLS; TAT PEPTIDE; ANTIBACTERIAL PEPTIDES; BOVINE NEUTROPHILS; DRUG-DELIVERY; HOST-DEFENSE; ANTENNAPEDIA HOMEODOMAIN; METABOLIC-INHIBITORS;
D O I
10.1007/s00249-011-0682-7
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Antimicrobial peptides (AMPs) are a group of peptides that are active against a diverse spectrum of microorganisms. Due to their mode of action, AMPs are a promising class of molecules that could overcome the problems of increasing resistance of bacteria to conventional antibiotics. Furthermore, AMPs are strongly membrane-active and some are able to translocate into cells without the necessity for permanent membrane permeabilization. This feature has brought them into focus for use as transport vectors in the context of drug delivery. Since the plasma membrane restricts transport of bioactive substances into cells, great research interest lies in the development of innovative ways to overcome this barrier and to increase bioavailability. In this context, peptide-based transport systems, such as cell-penetrating peptides (CPPs), have come into focus, and their efficiency has been demonstrated in many different applications. However, more recently, also some AMPs have been used as efficient vectors for intracellular translocation of various active molecules. This review summarizes recent efforts in this interesting field of drug delivery. Moreover, some examples of the application of CPPs as efficient antimicrobial substances will be discussed.
引用
收藏
页码:387 / 397
页数:11
相关论文
共 50 条
  • [41] Cell-penetrating peptides and their utility in genome function modifications
    Gagat, Maciej
    Zielinska, Wioletta
    Grzanka, Alina
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 (06) : 1615 - 1623
  • [42] Cell-penetrating peptides as a promising tool for delivery of various molecules into the cells
    Ruczynski, Jaroslaw
    Wierzbicki, Piotr M.
    Kogut-Wierzbicka, Marzena
    Mucha, Piotr
    Siedlecka-Kroplewska, Kamila
    Rekowski, Piotr
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2014, 52 (04) : 257 - 269
  • [43] Action of antimicrobial peptides and cell-penetrating peptides on membrane potential revealed by the single GUV method
    Moghal M.M.R.
    Hossain F.
    Yamazaki M.
    Biophysical Reviews, 2020, 12 (2) : 339 - 348
  • [44] Cell penetration: scope and limitations by the application of cell-penetrating peptides
    Reissmann, Siegmund
    JOURNAL OF PEPTIDE SCIENCE, 2014, 20 (10) : 760 - 784
  • [45] Cell-Penetrating Peptides and Polymers for Improved Drug Delivery
    Gui Lin
    Zhang Xue-Hao
    Qiao Zeng-Ying
    Wang Hao
    CHEMNANOMAT, 2020, 6 (08): : 1138 - 1148
  • [46] Early stages of interactions of cell-penetrating peptide penetratin with a DPPC bilayer
    Pourmousa, Mohsen
    Karttunen, Mikko
    CHEMISTRY AND PHYSICS OF LIPIDS, 2013, 169 : 85 - 94
  • [47] The Pharmacokinetics of Cell-Penetrating Peptides
    Sarko, Dikran
    Beijer, Barbro
    Boy, Regine Garcia
    Nothelfer, Eva-Maria
    Leotta, Karin
    Eisenhut, Michael
    Altmann, Annette
    Haberkorn, Uwe
    Mier, Walter
    MOLECULAR PHARMACEUTICS, 2010, 7 (06) : 2224 - 2231
  • [48] Oral biodrug delivery using cell-penetrating peptide
    Khafagy, El-Sayed
    Morishita, Mariko
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (06) : 531 - 539
  • [49] Prediction of cell-penetrating peptides
    Hällbrink, M
    Kilk, K
    Elmquist, A
    Lundberg, P
    Lindgren, M
    Jiang, Y
    Pooga, M
    Soomets, U
    Langel, Ü
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2005, 11 (04) : 249 - 259
  • [50] Cell-penetrating peptides: A tool for effective delivery in gene-targeted therapies
    de Figueiredo, Ines Rego
    Freire, Joao Miguel
    Flores, Luis
    Veiga, Ana Salome
    Castanho, Miguel A. R. B.
    IUBMB LIFE, 2014, 66 (03) : 182 - 194